Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Research and development tax breaks cut in Australia:

This article was originally published in Clinica

Executive Summary

Australia's federal government has withdrawn Aus$1,000 million ($770 million) in tax concessions to companies engaged in research and development. The tax incentive scheme will be replaced by a system of research grants. The move comes in response to widespread allegations of system abuse and escalating costs, say press reports. The Treasury Department estimated that only around 5% of investor syndicates which were in receipt of tax concessions were genuinely involved in R&D. However, there is concern that the restrictions will adversely affect genuine healthcare research in particular.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT088604

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel